Recursion
Dive into Recursion's innovative approach to decoding biology. Join our mission & explore what AI drug discovery companies can do. Contact us
User reviews and social mentions about "Recursion" mainly highlight its innovative approach to AI with unique features such as recursive observation and multi-agent orchestration. The main strength noted is the tool's ability to manage complex AI tasks efficiently through these recursive methodologies. However, some users express skepticism about its ability to compete with well-established solutions, particularly concerning AI consciousness and vulnerabilities. Pricing sentiment is not explicitly mentioned, but the tool's open-source nature suggests a positive reception. Overall, Recursion has a reputation for being a cutting-edge, open-source platform with a niche following among tech enthusiasts and developers.
Abridge
Download whitepaper
Users generally praise Abridge for its AI-driven capabilities, particularly in summarizing conversations effectively, which is seen as a major strength. However, complaints often center around occasional inaccuracies in transcription or summary details. The pricing is perceived as somewhat high by some users, but others feel it offers good value considering its utility in producing professional results quickly. Overall, Abridge has a positive reputation, especially admired by those who need efficient documentation tools.
Recursion
-67% vs last weekAbridge
Stable week-over-weekRecursion
Abridge
Recursion
Abridge
Recursion
Abridge
Recursion (1)
Abridge (8)
Only in Recursion (10)
Only in Abridge (1)
Only in Recursion (8)
Only in Abridge (15)
Recursion
Abridge
No complaints found
Recursion
Abridge
No data
Recursion
AI’s Current Proof Points in Drug Discovery – and the Next Frontier
Mar 26, 2026
Highlights from Recursion's Evening of Hope Event for Rare Disease Day 2026
Mar 24, 2026
An Evening of Hope: 2026 Rare Disease Day Event at Recursion
Mar 23, 2026
Recursion's Era of Value Realization: CFO Ben Taylor at Leerink Global Healthcare Conference
Mar 18, 2026
Recursion
Abridge
Recursion
The Mundane Risk
*The biggest near-term AI safety risks aren't dramatic — they're mundane. And that's precisely why they're* ***neglected****. This essay argues three things: (1) mundane AI failures are already causing measurable damage at scale, (2) current alignment approaches may depend more heavily on sandboxed
Abridge
Shared (1)
Only in Recursion (1)
Only in Abridge (1)
